Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 257

1.

Lead Extraction With Baffle Stenting in Adults With Transposition of the Great Arteries.

Laredo M, Waldmann V, Chaix MA, Ibrahim R, Casteigt B, Dubuc M, Thibault B, Asgar AW, Dore A, Mongeon FP, Khairy P, Mondésert B.

JACC Clin Electrophysiol. 2019 Jun;5(6):671-680. doi: 10.1016/j.jacep.2019.01.023. Epub 2019 Mar 27.

PMID:
31221353
2.

Piloting a surveillance system for HIV drug resistance in the European Union.

van de Laar MJ, Bosman A, Pharris A, Andersson E, Assoumou L, Ay E, Bannert N, Bartmeyer B, Brady M, Chaix ML, Descamps D, Dauwe K, Fonager J, Hauser A, Lunar M, Mezei M, Neary M, Poljak M, van Sighem A, Verhofstede C, Amato-Gauci AJ, Broberg EK.

Euro Surveill. 2019 May;24(19). doi: 10.2807/1560-7917.ES.2019.24.19.1800390.

3.

Real-life activity of eribulin mesylate among metastatic breast cancer patients in the multicenter national observational ESME program.

Jacot W, Heudel PE, Fraisse J, Gourgou S, Guiu S, Dalenc F, Pistilli B, Campone M, Levy C, Debled M, Leheurteur M, Chaix M, Lefeuvre C, Goncalves A, Uwer L, Ferrero JM, Eymard JC, Petit T, Mouret-Reynier MA, Courtinard C, Cottu P, Robain M, Mailliez A.

Int J Cancer. 2019 May 14. doi: 10.1002/ijc.32402. [Epub ahead of print]

PMID:
31087564
4.

In-depth Sampling of High-risk Populations to Characterize HIV Transmission Epidemics Among Young MSM Using PrEP in France and Quebec.

Chaillon A, Delaugerre C, Brenner B, Armero A, Capitant C, Nere ML, Leturque N, Pialoux G, Cua E, Tremblay C, Smith DM, Goujard C, Meyer L, Molina JM, Chaix ML.

Open Forum Infect Dis. 2019 Feb 15;6(3):ofz080. doi: 10.1093/ofid/ofz080. eCollection 2019 Mar.

5.

Sudden death in transposition of the great arteries with atrial switch surgery: Autopsy evidence of acute myocardial ischemia despite normal coronary arteries.

Chaix MA, Chergui M, Leduc C, Khairy P.

Int J Cardiol. 2019 Aug 1;288:65-67. doi: 10.1016/j.ijcard.2019.02.026. Epub 2019 Feb 14.

PMID:
30808604
6.

Variability in the Echocardiographic Evaluation of the Systemic Right Ventricle.

Chaix MA, Dore A, Marcotte F, Shohoudi A, Labombarda F, Mercier LA, Proietti A, Ibrahim R, Asgar AW, Mondésert B, Poirier N, Khairy P, Mongeon FP.

Can J Cardiol. 2019 Feb;35(2):178-184. doi: 10.1016/j.cjca.2018.11.021. Epub 2018 Nov 30.

PMID:
30760424
7.

Stable prevalence of transmitted drug resistance mutations and increased circulation of non-B subtypes in antiretroviral-naive chronically HIV-infected patients in 2015/2016 in France.

Assoumou L, Bocket L, Pallier C, Grude M, Ait-Namane R, Izopet J, Raymond S, Charpentier C, Visseaux B, Wirden M, Trabaud MA, Le Guillou-Guillemette H, Allaoui C, Henquell C, Krivine A, Dos Santos G, Delamare C, Bouvier-Alias M, Montes B, Ferre V, De Monte A, Signori-Schmuck A, Maillard A, Morand-Joubert L, Tumiotto C, Fafi-Kremer S, Amiel C, Barin F, Marque-Juillet S, Courdavault L, Vallet S, Beby-Defaux A, de Rougemont A, Fenaux H, Avettand-Fenoel V, Allardet-Servent A, Plantier JC, Peytavin G, Calvez V, Chaix ML, Descamps D; ANRS AC-43 Resistance Study Group .

J Antimicrob Chemother. 2019 Feb 11. doi: 10.1093/jac/dkz011. [Epub ahead of print]

PMID:
30753724
8.

Evolution of the Envelope Glycoprotein of HIV-1 Clade B toward Higher Infectious Properties over the Course of the Epidemic.

Bouvin-Pley M, Beretta M, Moreau A, Roch E, Essat A, Goujard C, Chaix ML, Moiré N, Martin L, Meyer L, Barin F, Braibant M.

J Virol. 2019 Mar 5;93(6). pii: e01171-18. doi: 10.1128/JVI.01171-18. Print 2019 Mar 15.

PMID:
30567994
9.

Effect of On-Demand Oral Pre-exposure Prophylaxis With Tenofovir/Emtricitabine on Herpes Simplex Virus-1/2 Incidence Among Men Who Have Sex With Men: A Substudy of the ANRS IPERGAY Trial.

Chaix ML, Charreau I, Pintado C, Delaugerre C, Mahjoub N, Cotte L, Capitant C, Raffi F, Cua E, Pialoux G, Tremblay C, Meyer L, Molina JM; ANRS IPERGAY Study Group .

Open Forum Infect Dis. 2018 Nov 8;5(11):ofy295. doi: 10.1093/ofid/ofy295. eCollection 2018 Nov.

10.

Comparative performance of the Biocentric Generic Viral Load, Roche CAP/CTM v1.5, Roche CAP/CTM v2.0 and m2000 Abbott assays for quantifying HIV-1 B and non-B strains: Underestimation of some CRF02 strains.

Avettand-Fénoël V, Mélard A, Gueudin M, Maillard A, Dina J, Gousset M, Chaix ML, Lerolle N, Viard JP, Meyer L, Plantier JC, Rouzioux C; ANRS-AC11 HIV Quantification Working Group.

J Clin Virol. 2019 Jan;110:36-41. doi: 10.1016/j.jcv.2018.12.002. Epub 2018 Dec 3.

PMID:
30530097
11.

HIV rapid screening tests and self-tests: Be aware of differences in performance and cautious of vendors.

Mourez T, Lemée V, Delbos V, Delaugerre C, Alessandri-Gradt E, Etienne M, Simon F, Chaix ML, Plantier JC.

EBioMedicine. 2018 Nov;37:382-391. doi: 10.1016/j.ebiom.2018.10.012. Epub 2018 Oct 24.

12.

Once-daily darunavir/ritonavir 400/100 mg in triple therapy: efficacy and penetration in seminal compartment in ANRS-165 DARULIGHT study.

Lê MP, Chaix ML, Raffi F, Chevret S, Gallien S, Katlama C, Delobel P, Yazdanpanah Y, Saillard J, Molina JM, Peytavin G; ANRS-165 DARULIGHT study group.

Br J Clin Pharmacol. 2019 Jan;85(1):277-280. doi: 10.1111/bcp.13796. Epub 2018 Nov 12. No abstract available.

PMID:
30421447
13.

Prevalence of pretreatment HIV drug resistance in West African and Southeast Asian countries.

Ngo-Giang-Huong N, Huynh THK, Dagnra AY, Toni TD, Maiga AI, Kania D, Eymard-Duvernay S, Peeters M, Soulie C, Peytavin G, Rekacewicz C, Chaix ML, Aghokeng AF; ANRS 12333 Study Group .

J Antimicrob Chemother. 2019 Feb 1;74(2):462-467. doi: 10.1093/jac/dky443.

14.

Sensitivity to Broadly Neutralizing Antibodies of Recently Transmitted HIV-1 Clade CRF02_AG Viruses with a Focus on Evolution over Time.

Stefic K, Bouvin-Pley M, Essat A, Visdeloup C, Moreau A, Goujard C, Chaix ML, Braibant M, Meyer L, Barin F.

J Virol. 2019 Jan 4;93(2). pii: e01492-18. doi: 10.1128/JVI.01492-18. Print 2019 Jan 15.

15.

Viral rebound in semen after antiretroviral treatment interruption in an HIV therapeutic vaccine double-blind trial.

Palich R, Ghosn J, Chaillon A, Boilet V, Nere ML, Chaix ML, Delobel P, Molina JM, Lucht F, Bouchaud O, Rieux V, Thiebaut R, Levy Y, Delaugerre C, Lelievre JD; VRI02/ANRS149 LIGHT Vaccine Trial Group.

AIDS. 2019 Feb 1;33(2):279-284. doi: 10.1097/QAD.0000000000002058.

PMID:
30325777
16.

Ultra-deep sequencing improves the detection of drug resistance in cellular DNA from HIV-infected patients on ART with suppressed viraemia.

Rodriguez C, Nere ML, Demontant V, Charreau I, Mercier-Darty M, Delagreverie H, Salmona M, de Castro N, Chaix ML, Molina JM, Delaugerre C.

J Antimicrob Chemother. 2018 Nov 1;73(11):3122-3128. doi: 10.1093/jac/dky315.

PMID:
30137335
17.

Phenotypic properties of envelope glycoproteins of transmitted HIV-1 variants from patients belonging to transmission chains.

Beretta M, Moreau A, Bouvin-Pley M, Essat A, Goujard C, Chaix ML, Hue S, Meyer L, Barin F, Braibant M; ANRS 06 Primo Cohort.

AIDS. 2018 Sep 10;32(14):1917-1926. doi: 10.1097/QAD.0000000000001906.

PMID:
29927786
18.

Pharmacokinetic modelling of darunavir/ritonavir dose reduction (800/100 to 400/100 mg once daily) in a darunavir/ritonavir-containing regimen in virologically suppressed HIV-infected patients: ANRS 165 DARULIGHT sub-study.

Lê MP, Chaix ML, Chevret S, Bertrand J, Raffi F, Gallien S, El Abbassi EMB, Katlama C, Delobel P, Yazdanpanah Y, Saillard J, Molina JM, Peytavin G; ANRS 165 DARULIGHT Study Group .

J Antimicrob Chemother. 2018 Aug 1;73(8):2120-2128. doi: 10.1093/jac/dky193.

PMID:
29905808
19.

Low-dose ritonavir-boosted darunavir in virologically suppressed HIV-1-infected adults: an open-label trial (ANRS 165 Darulight).

Molina JM, Gallien S, Chaix ML, El Abbassi EM, Madelaine I, Katlama C, Valin N, Delobel P, Desseaux K, Peytavin G, Saillard J, Raffi F, Chevret S; ANRS 165 Darulight Study Group .

J Antimicrob Chemother. 2018 Aug 1;73(8):2129-2136. doi: 10.1093/jac/dky181.

PMID:
29860402
20.

Prevalence of drug resistance in children recently diagnosed with HIV-1 infection in France (2006-17): impact on susceptibility to first-line strategies.

Frange P, Avettand-Fenoel V, Veber F, Blanche S, Chaix ML.

J Antimicrob Chemother. 2018 Sep 1;73(9):2475-2479. doi: 10.1093/jac/dky203.

PMID:
29846602
21.

Emerging resistance mutations in PI-naive patients failing an atazanavir-based regimen (ANRS multicentre observational study).

Lambert-Niclot S, Grude M, Chaix ML, Charpentier C, Reigadas S, Le Guillou-Guillemette H, Rodallec A, Amiel C, Maillard A, Dufayard J, Mourez T, Mirand A, Guinard J, Montes B, Vallet S, Marcelin AG, Descamps D, Flandre P, Delaugerre C, Morand-Joubert L; ANRS AC-11 Resistance Group .

J Antimicrob Chemother. 2018 Aug 1;73(8):2147-2151. doi: 10.1093/jac/dky142.

PMID:
29718247
22.

Detection of numerous HIV-1/MO recombinants in France.

De Oliveira F, Cappy P, Lemée V, Moisan A, Pronier C, Bocket L, Bouvier-Alias M, Chaix ML, Gault E, Morvan O, Poveda JD, Schneider V, Wirden M, Alessandri-Gradt E, Mourez T, Plantier JC.

AIDS. 2018 Jun 19;32(10):1289-1299. doi: 10.1097/QAD.0000000000001814.

PMID:
29683851
23.

Transmission of Hepatitis E Virus With Plasma Exchange in Kidney Transplant Recipients: A Retrospective Cohort Study.

Mallet V, Sberro-Soussan R, Roque-Afonso AM, Vallet-Pichard A, Deau B, Portal A, Chaix ML, Hauser L, Beylouné A, Mercadier A, Izopet J, Legendre C, Pol S.

Transplantation. 2018 Aug;102(8):1351-1357. doi: 10.1097/TP.0000000000002185.

PMID:
29561324
24.

Nonreactive Human Immunodeficiency Virus Type 1 Rapid Tests After Sustained Viral Suppression Following Antiretroviral Therapy Initiation During Primary Infection.

Stefic K, Novelli S, Mahjoub N, Seng R, Molina JM, Cheneau C, Barin F, Chaix ML, Meyer L, Delaugerre C; French National Agency for Research on AIDS and Viral Hepatitis (ANRS) PRIMO Study Group .

J Infect Dis. 2018 May 5;217(11):1793-1797. doi: 10.1093/infdis/jiy120.

PMID:
29509924
25.

Transvenous Lead Extraction in Adults With Congenital Heart Disease: Insights From a 20-Year Single-Center Experience.

Gourraud JB, Chaix MA, Shohoudi A, Pagé P, Dubuc M, Thibault B, Poirier NC, Dore A, Marcotte F, Mongeon FP, Asgar AW, Ibrahim R, Khairy P, Mondésert B.

Circ Arrhythm Electrophysiol. 2018 Feb;11(2):e005409. doi: 10.1161/CIRCEP.117.005409.

PMID:
29437760
26.

Temporal trends of transmitted HIV drug resistance in a multinational seroconversion cohort.

Olson A, Bannert N, Sönnerborg A, de Mendoza C, Price M, Zangerle R, Chaix ML, Prins M, Kran AB, Gill J, Paraskevis D, Porter K; for CASCADE Collaboration in EuroCoord.

AIDS. 2018 Jan 14;32(2):161-169. doi: 10.1097/QAD.0000000000001689.

PMID:
29112061
27.

CD4 T cell decline following HIV seroconversion in individuals with and without CXCR4-tropic virus.

Ghosn J, Bayan T, Meixenberger K, Tran L, Frange P, d'Arminio Monforte A, Zangerle R, de Mendoza C, Krastinova E, Porter K, Meyer L, Chaix ML; CASCADE Collaboration in EuroCoord.

J Antimicrob Chemother. 2017 Oct 1;72(10):2862-2868. doi: 10.1093/jac/dkx247.

PMID:
29091208
28.

Late Onset Postcapillary Pulmonary Hypertension in Patients With Transposition of the Great Arteries and Mustard or Senning Baffles.

Chaix MA, Dore A, Mercier LA, Mongeon FP, Marcotte F, Ibrahim R, Asgar AW, Shohoudi A, Labombarda F, Mondésert B, Poirier N, Khairy P.

J Am Heart Assoc. 2017 Oct 12;6(10). pii: e006481. doi: 10.1161/JAHA.117.006481.

29.

Characterization of a Human Induced Pluripotent Stem Cell-Derived Cardiomyocyte Model for the Study of Variant Pathogenicity: Validation of a KCNJ2 Mutation.

Gélinas R, El Khoury N, Chaix MA, Beauchamp C, Alikashani A, Ethier N, Boucher G, Villeneuve L, Robb L, Latour F, Mondesert B, Rivard L, Goyette P, Talajic M, Fiset C, Rioux JD.

Circ Cardiovasc Genet. 2017 Oct;10(5). pii: e001755. doi: 10.1161/CIRCGENETICS.117.001755.

PMID:
29021306
30.

Penetration and antiviral efficacy of total and unbound maraviroc, raltegravir and rilpivirine in both female and male genital fluids from HIV-positive patients receiving regimens containing these antiretrovirals.

Lê MP, Belarbi L, Chaix ML, Dulioust E, Mahjoub N, Salmon D, Viard JP, Duvivier C, Peytavin G, Launay O, Ghosn J.

J Antimicrob Chemother. 2017 Nov 1;72(11):3167-3171. doi: 10.1093/jac/dkx275.

PMID:
28961979
31.

Multicenter comparison of the new Cobas 6800 system with Cobas Ampliprep/Cobas TaqMan and Abbott RealTime for the quantification of HIV, HBV and HCV viral load.

Wirden M, Larrouy L, Mahjoub N, Todesco E, Damond F, Delagreverie H, Akhavan S, Charpentier C, Chaix ML, Descamps D, Calvez V, Marcelin AG.

J Clin Virol. 2017 Nov;96:49-53. doi: 10.1016/j.jcv.2017.09.007. Epub 2017 Sep 20.

PMID:
28950186
32.

Detectable HIV-RNA in semen of HIV controllers.

Chaix ML, Boufassa F, Meyzer C, Leruez-Ville M, Mahjoub N, Nere ML, Genet P, Duvivier C, Lascoux-Combes C, Lambotte O, Ghosn J.

PLoS One. 2017 Aug 16;12(8):e0183376. doi: 10.1371/journal.pone.0183376. eCollection 2017.

33.

Increasing Prevalence of Atrial Fibrillation and Permanent Atrial Arrhythmias in Congenital Heart Disease.

Labombarda F, Hamilton R, Shohoudi A, Aboulhosn J, Broberg CS, Chaix MA, Cohen S, Cook S, Dore A, Fernandes SM, Fournier A, Kay J, Macle L, Mondésert B, Mongeon FP, Opotowsky AR, Proietti A, Rivard L, Ting J, Thibault B, Zaidi A, Khairy P; AARCC.

J Am Coll Cardiol. 2017 Aug 15;70(7):857-865. doi: 10.1016/j.jacc.2017.06.034.

34.

Assessment of HIV Screening Tests for Use in Preexposure Prophylaxis Programs.

Delaugerre C, Antoni G, Mahjoub N, Pialoux G, Cua E, Pasquet A, Hall N, Tremblay C, Cotte L, Capitant C, Chaix ML, Meyer L, Molina JM; IPERGAY Study Group.

J Infect Dis. 2017 Aug 1;216(3):382-386. doi: 10.1093/infdis/jix297.

PMID:
28666370
35.

Sudden Cardiac Death in Adult Congenital Heart Disease.

Ávila P, Chaix MA, Mondésert B, Khairy P.

Card Electrophysiol Clin. 2017 Jun;9(2):225-234. doi: 10.1016/j.ccep.2017.02.003. Epub 2017 Mar 18. Review.

PMID:
28457237
36.

Prevalence of HIV-1 drug resistance in treated patients with viral load >50 copies/mL: a 2014 French nationwide study.

Assoumou L, Charpentier C, Recordon-Pinson P, Grudé M, Pallier C, Morand-Joubert L, Fafi-Kremer S, Krivine A, Montes B, Ferré V, Bouvier-Alias M, Plantier JC, Izopet J, Trabaud MA, Yerly S, Dufayard J, Alloui C, Courdavault L, Le Guillou-Guillemette H, Maillard A, Amiel C, Vabret A, Roussel C, Vallet S, Guinard J, Mirand A, Beby-Defaux A, Barin F, Allardet-Servent A, Ait-Namane R, Wirden M, Delaugerre C, Calvez V, Chaix ML, Descamps D, Reigadas S; ANRS AC-11 Resistance Study Group.

J Antimicrob Chemother. 2017 Jun 1;72(6):1769-1773. doi: 10.1093/jac/dkx042.

PMID:
28333232
37.

Spatiotemporal dynamics of HIV-1 transmission in France (1999-2014) and impact of targeted prevention strategies.

Chaillon A, Essat A, Frange P, Smith DM, Delaugerre C, Barin F, Ghosn J, Pialoux G, Robineau O, Rouzioux C, Goujard C, Meyer L, Chaix ML; on behalf the ANRS PRIMO Cohort Study.

Retrovirology. 2017 Feb 21;14(1):15. doi: 10.1186/s12977-017-0339-4.

38.

First description of a double heterozygosity for BRCA1 and BRCA2 pathogenic variants in a French metastatic breast cancer patient: A case report.

Meynard G, Mansi L, Lebahar P, Villanueva C, Klajer E, Calcagno F, Vivalta A, Chaix M, Collonge-Rame MA, Populaire C, Algros MP, Colpart P, Neidich J, Pivot X, Curtit E.

Oncol Rep. 2017 Mar;37(3):1573-1578. doi: 10.3892/or.2017.5422. Epub 2017 Feb 3.

PMID:
28184945
39.

[The anti-tumor immune response in breast cancer: Update and therapeutic perspectives].

Ladoire S, Derangère V, Arnould L, Thibaudin M, Coudert B, Lorgis V, Desmoulins I, Chaix M, Fumoleau P, Ghiringhelli F.

Ann Pathol. 2017 Feb;37(1):133-141. doi: 10.1016/j.annpat.2016.12.012. Epub 2017 Jan 31. Review. French.

PMID:
28159406
40.

Unravelling the dynamics of selection of multiresistant variants to integrase inhibitors in an HIV-1-infected child using ultra-deep sequencing.

Stefic K, Salmona M, Capitao M, Splittgerber M, Maakaroun-Vermesse Z, Néré ML, Bernard L, Chaix ML, Barin F, Delaugerre C.

J Antimicrob Chemother. 2017 Mar 1;72(3):850-854. doi: 10.1093/jac/dkw507.

PMID:
27999055
41.

TECRL, a new life-threatening inherited arrhythmia gene associated with overlapping clinical features of both LQTS and CPVT.

Devalla HD, Gélinas R, Aburawi EH, Beqqali A, Goyette P, Freund C, Chaix MA, Tadros R, Jiang H, Le Béchec A, Monshouwer-Kloots JJ, Zwetsloot T, Kosmidis G, Latour F, Alikashani A, Hoekstra M, Schlaepfer J, Mummery CL, Stevenson B, Kutalik Z, de Vries AA, Rivard L, Wilde AA, Talajic M, Verkerk AO, Al-Gazali L, Rioux JD, Bhuiyan ZA, Passier R.

EMBO Mol Med. 2016 Dec 1;8(12):1390-1408. doi: 10.15252/emmm.201505719. Print 2016 Dec.

42.

First next-generation sequencing full-genome characterization of a hepatitis C virus genotype 7 divergent subtype.

Salmona M, Caporossi A, Simmonds P, Thélu MA, Fusillier K, Mercier-Delarue S, De Castro N, LeGoff J, Chaix ML, François O, Simon F, Morand P, Larrat S, Maylin S.

Clin Microbiol Infect. 2016 Nov;22(11):947.e1-947.e8. doi: 10.1016/j.cmi.2016.07.032. Epub 2016 Aug 8.

43.

Positive impact of autophagy in human breast cancer cells on local immunosurveillance.

Ladoire S, Enot D, Senovilla L, Chaix M, Zitvogel L, Kroemer G.

Oncoimmunology. 2016 May 24;5(6):e1174801. doi: 10.1080/2162402X.2016.1174801. eCollection 2016 Jun.

44.

Pharmacodynamics, pharmacokinetics and clinical efficacy of neratinib in HER2-positive breast cancer and breast cancer with HER2 mutations.

Kourie HR, Chaix M, Gombos A, Aftimos P, Awada A.

Expert Opin Drug Metab Toxicol. 2016 Aug;12(8):947-57. doi: 10.1080/17425255.2016.1198317. Epub 2016 Jun 27. Review.

PMID:
27284682
45.

The global spread of HIV-1 subtype B epidemic.

Magiorkinis G, Angelis K, Mamais I, Katzourakis A, Hatzakis A, Albert J, Lawyer G, Hamouda O, Struck D, Vercauteren J, Wensing A, Alexiev I, Åsjö B, Balotta C, Gomes P, Camacho RJ, Coughlan S, Griskevicius A, Grossman Z, Horban A, Kostrikis LG, Lepej SJ, Liitsola K, Linka M, Nielsen C, Otelea D, Paredes R, Poljak M, Puchhammer-Stöckl E, Schmit JC, Sönnerborg A, Staneková D, Stanojevic M, Stylianou DC, Boucher CAB; SPREAD program, Nikolopoulos G, Vasylyeva T, Friedman SR, van de Vijver D, Angarano G, Chaix ML, de Luca A, Korn K, Loveday C, Soriano V, Yerly S, Zazzi M, Vandamme AM, Paraskevis D.

Infect Genet Evol. 2016 Dec;46:169-179. doi: 10.1016/j.meegid.2016.05.041. Epub 2016 Jun 2.

46.

Genetic testing in congenital heart disease: A clinical approach.

Chaix MA, Andelfinger G, Khairy P.

World J Cardiol. 2016 Feb 26;8(2):180-91. doi: 10.4330/wjc.v8.i2.180. Review.

47.

The presence of LC3B puncta and HMGB1 expression in malignant cells correlate with the immune infiltrate in breast cancer.

Ladoire S, Enot D, Senovilla L, Ghiringhelli F, Poirier-Colame V, Chaba K, Semeraro M, Chaix M, Penault-Llorca F, Arnould L, Poillot ML, Arveux P, Delaloge S, Andre F, Zitvogel L, Kroemer G.

Autophagy. 2016 May 3;12(5):864-75. doi: 10.1080/15548627.2016.1154244. Epub 2016 Mar 16.

48.

Novel CALM3 mutations in pediatric long QT syndrome patients support a CALM3-specific calmodulinopathy.

Chaix MA, Koopmann TT, Goyette P, Alikashani A, Latour F, Fatah M, Hamilton RM, Rioux JD.

HeartRhythm Case Rep. 2016 Mar 16;2(3):250-254. doi: 10.1016/j.hrcr.2016.02.002. eCollection 2016 May. No abstract available.

49.

Human ectonucleotidase-expressing CD25high Th17 cells accumulate in breast cancer tumors and exert immunosuppressive functions.

Thibaudin M, Chaix M, Boidot R, Végran F, Derangère V, Limagne E, Berger H, Ladoire S, Apetoh L, Ghiringhelli F.

Oncoimmunology. 2015 Jul 6;5(1):e1055444. eCollection 2016.

50.

Risks and Benefits of Exercise Training in Adults With Congenital Heart Disease.

Chaix MA, Marcotte F, Dore A, Mongeon FP, Mondésert B, Mercier LA, Khairy P.

Can J Cardiol. 2016 Apr;32(4):459-66. doi: 10.1016/j.cjca.2015.12.007. Epub 2015 Dec 18. Review.

PMID:
26868839

Supplemental Content

Support Center